Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
138.15B | 152.41B | 125.93B | 110.05B | 95.31B | 81.59B | Gross Profit |
72.88B | 84.66B | 73.82B | 63.01B | 52.74B | 40.95B | EBIT |
45.92B | 57.08B | 50.81B | 42.91B | 34.60B | 22.83B | EBITDA |
50.32B | 63.56B | 54.25B | 46.30B | 37.39B | 25.62B | Net Income Common Stockholders |
35.19B | 43.37B | 36.74B | 32.55B | 24.92B | 15.95B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
125.19B | 125.19B | 102.12B | 107.26B | 71.24B | 65.66B | Total Assets |
243.48B | 243.48B | 217.37B | 187.37B | 163.71B | 143.47B | Total Debt |
12.16B | 12.16B | 11.75B | 6.10B | 6.83B | 7.93B | Net Debt |
-113.03B | -113.03B | -90.36B | -101.17B | -64.41B | -57.73B | Total Liabilities |
48.39B | 48.40B | 56.24B | 40.89B | 42.92B | 43.73B | Stockholders Equity |
195.08B | 195.08B | 161.13B | 146.47B | 120.80B | 99.73B |
Cash Flow | Free Cash Flow | ||||
29.17B | 31.79B | 14.37B | 42.88B | 11.50B | 19.94B | Operating Cash Flow |
33.35B | 36.92B | 21.79B | 46.95B | 14.63B | 22.28B | Investing Cash Flow |
-4.93B | -5.96B | -7.68B | -7.43B | -4.23B | -8.44B | Financing Cash Flow |
-16.65B | -15.97B | -22.48B | -9.98B | -6.96B | -6.35B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $74.32B | 17.11 | 23.93% | 2.13% | 1.26% | 6.84% | |
76 Outperform | $37.74B | 35.44 | 16.13% | 0.50% | -0.81% | -9.28% | |
74 Outperform | $12.07B | 37.81 | 22.64% | 0.59% | -18.33% | -11.92% | |
73 Outperform | $55.42B | ― | -460.30% | ― | 30.24% | 27.61% | |
63 Neutral | $1.75B | 12.43 | -220.61% | 8.37% | 1.64% | -32.31% | |
60 Neutral | $14.06B | 6.51 | -3.76% | 3.69% | 2.48% | -35.40% | |
57 Neutral | $41.42B | ― | -114.76% | ― | 5.31% | -15.57% |